Pharmacogenetics of OPRM1

This publication has 113 references indexed in Scilit:

• The human μ-opioid receptor gene polymorphism (A118G) is associated with head pain severity in a clinical cohort of female migraine with aura patients
  The Journal of Headache and Pain, 2012
• Common and specific liability to addiction: Approaches to association studies of opioid addiction
  Drug and Alcohol Dependence, 2012
• Functional relevance of μ–δ opioid receptor heteromerization: A Role in novel signaling and implications for the treatment of addiction disorders: From a symposium on new concepts in mu-opioid pharmacology
  Drug and Alcohol Dependence, 2012
• No evidence of association between 118A>G OPRM1 polymorphism and heroin dependence in a large Bulgarian case–control sample
  Drug and Alcohol Dependence, 2011
• Genetic variability of the μ-opioid receptor influences intrathecal fentanyl analgesia requirements in laboring women ☆
  Pain, 2008
• Nicotine abstinence-induced cerebral blood flow changes by genotype
  Neuroscience Letters, 2008
• An Evaluation of μ-Opioid Receptor (OPRM1) as a Predictor of Naltrexone Response in the Treatment of Alcohol Dependence
  Archives of General Psychiatry, 2008
• Update on neuropharmacological treatments for alcoholism: Scientific basis and clinical findings
  Biochemical Pharmacology, 2008
• Evaluation of OPRM1 variants in heroin dependence by family-based association testing and meta-analysis
  Drug and Alcohol Dependence, 2007
• Exploring joint effects of genes and the clinical efficacy of morphine for cancer pain: OPRM1 and COMT gene
  Pain, 2007